Trends of Ten Leading Causes of Death in Head and Neck Squamous Cell Carcinoma

Abstract

Objective

An understanding of the leading causes of death in patients with head and neck squamous cell carcinoma (HNSCC) would be helpful to inform doctors, patients, and healthcare providers on disease management. This study aimed to comprehensively study the leading causes of death in these survivors.

Methods

We investigated the trends of risk factors for major causes of death in patients with HNSCC. Causes of death in HNSCC were obtained from the Surveillance, Epidemiology, and End Results registries. We characterized trends in the 5-year cumulative mortality as well as risk factors associated with the ten leading causes of death.

Results

Among 48 297 deaths identified, the ten leading causes were as follows: HNSCC, heart disease, lung cancer, chronic obstructive pulmonary disease (COPD), cerebrovascular disease, pneumonia & influenza, accidents & adverse effects, esophagus cancer, chronic liver diseases, and septicemia. Non-HNSCC deaths surpassed HNSCC deaths 4 years after cancer diagnosis. There was a significant decline in the 5-year cumulative mortality from HNSCC, heart disease, lung cancer, COPD, cerebrovascular disease, and esophagus cancer. The risks of mortality from the ten leading causes varied with patient characteristics.

Conclusion

Our findings provide a useful picture of mortality patterns in HNSCC survivors, which might help when planning personalized HNSCC care.

Keywords

cause of death / head and neck / heart disease / squamous cell carcinoma / trend

References

[1] EdwardsBK, NooneNA, MariottoAB, et al.. Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 2014, 120(9): 1290-1314

[2] PulteD, BrennerH. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist, 2010, 15(9): 994-1001

[3] CohenEE, LaMonteSJ, ErbNL, et al.. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin, 2016, 66(3): 203-239

[4] RyuCH, RohJL, KimSB, et al.. Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma. Ann Oncol, 2013, 24(4): 1049-1054

[5] van der SchroeffMP, van de SchansSAM, PiccirilloJF, et al.. Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors. Head Neck, 2010, 32(12): 1613-1618

[6] FullerCD, WangSJ, ThomasCRJr, et al.. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973–1998. Cancer, 2007, 109(7): 1331-1343

[7] BouillonK, HaddyN, DelalogeS, et al.. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol, 2011, 57(4): 445-452

[8] BaxiSS, PinheiroLC, PatilSM, et al.. Causes of death in long-term survivors of head and neck cancer. Cancer, 2014, 120(10): 1507-1513

[9] van MonsjouHS, SchaapveldM, Hamming-VriezeO, et al.. Cause-specific excess mortality in patients treated for cancer of the oral cavity and oropharynx: A population-based study. Oral Oncol, 2016, 52: 37-44

[10] Surveillance, Epidemiology, and End Results (SEER) Program (https://www.seer.cancer.gov) Research Data (1975-2016), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission. Accessed 20 Dec 2019.

[11] National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Head and Neck Cancers. Version 1.2020 — February 12, 2020. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf (Accessed March 10, 2020).

[12] SturgeonKM, DengL, BluethmannSM, et al.. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J, 2019, 40(48): 3889-3897

[13] JasonPF, GrayGR. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc, 2012, 94: 496-5091999

[14] JiangB, WangWZ, ChenH, et al.. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke, 2006, 37(1): 63-68

[15] BauerUE, BrissPA, GoodmanRA, et al.. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet, 2014, 384(9937): 45-52

[16] HavranekEP, MujahidMS, BarrDA, et al.. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation, 2015, 132(9): 873-898

[17] ZaorskyNG, ChurillaTM, EglestonBL, et al.. Causes of death among cancer patients. Ann Oncol, 2017, 28(2): 400-407

[18] BigelowEO, BlackfordAL, EytanDF, et al.. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls. Cancer, 2020, 126(8): 1793-1803

[19] LeeM, KowdleyKV. Alcohol’s effect on other chronic liver diseases. Clin Liver Dis, 2012, 16(4): 827-837

[20] FlorouAN, GkiozosIC, TsagouliSK, et al.. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir Care, 2014, 59(12): 1924-1936

[21] TabuchiT, GotoA, ItoY, et al.. Smoking at the time of diagnosis and mortality in cancer patients: What benefit does the quitter gain?. Int J Cancer, 2017, 140(8): 1789-1795

[22] Vander ArkWD, DiNardoLJ, OliverDS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope, 1997, 107(7): 888-892

[23] DuffySA, RonisDL, ValensteinM, et al.. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2203-220822

[24] BreslowRA, ChenCM, GraubardBI, et al.. Prospective study of alcohol consumption quantity and frequency and cancer-specific mortality in the US population. Am J Epidemiol, 2011, 174(9): 1044-1053

[25] CaiS, LiY, DingY, et al.. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev, 2014, 23(6): 532-539

[26] Deaths by influenza and pneumonia in the U.S. from 1950 to 2017. https://www.statista.com/statistics/184574/deaths-by-influenza-and-pneumonia-in-the-us-since-1950/). Release date October, 2019.

[27] GoldsteinE, LipsitchM. The relation between prescribing of different antibiotics and rates of mortality with sepsis in US adults. BMC Infect Dis, 2020, 20(1): 169

[28] MirabileA, NumicoG, RussiEG, et al.. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. Crit Rev Oncol Hematol, 2015, 95(2): 191-213

[29] ZhangY, WangR, MiaoL, et al.. Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013. PLoS One, 2015, 10(4): e0124045

[30] SturgisEM, CinciripiniPM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer, 2007, 110(7): 1429-1435

[31] YouEL, HenryM, ZeitouniAG. Human Papillomavirus-Associated Oropharyngeal Cancer: Review of Current Evidence and Management. Curr Oncol, 2019, 26(2): 119-123

[32] HeronM. Deaths: Leading Causes for 2016. Natl Vital Stat Rep, 2018, 67(6): 1-77